(paper,1)
(parameters,,1)
(Superior-Inferior,1)
(event,1)
(improve,1)
(s),,1)
(uncertainties,1)
(include,1)
(signal.,1)
(Results:,1)
(cytoplasm,1)
(mm,,1)
(over,3)
(responses,1)
(minimum,1)
((SBRT),1)
(vitro,1)
(target/PTV,1)
(intercellular,1)
(presented,1)
(inhibitor,2)
(glucose-regulated,1)
(urgently,1)
(Xue,,1)
(fluoroscopic,1)
(Western,1)
(causally,1)
(are,3)
(recommend,1)
(efficacy,1)
(classic,1)
(element,1)
(sites,1)
(VMAT,2)
(monitoring,2)
(intervals:,1)
(toxin,1)
(Gan,,1)
(Q.-Z.,,1)
(Cranial,1)
(cocultured,1)
(our,2)
(functionally,2)
(exome,1)
(electromagnetic,1)
(B.,1)
(temsirolimus),1)
(complexity,2)
(alterations.,2)
(subunit,1)
(namely,1)
(planned,1)
(induced,3)
(S100A16,9)
(PHB-1,1)
(up-regulation,1)
(aggressive,1)
(long,1)
(found,3)
(digoxin,1)
(mTOR,1)
(associated,3)
(pre-treatment,1)
(serum,1)
(Prompt,1)
(HSPB1,,1)
(tumors,1)
(shows,1)
(estimated,1)
(translations,1)
(new,2)
(acquired,2)
(We,4)
(44,1)
(four-dimensional,1)
(Despite,1)
(conflicting,1)
(characteristics,1)
(treatment,9)
(suggest,1)
(allows,1)
(T,2)
(CBCT.,1)
(4,,1)
(siRNAs,1)
(-0.0��0.7,1)
(covered,2)
((AMPAR).,1)
(Targets,1)
(places,1)
(correction.,1)
(plans,1)
(requires,1)
(behavior,1)
(six,1)
(51-year-old,1)
(transforming,1)
(often,1)
(X.-G.,,1)
(V/propidium,1)
(knowledge,1)
(predilection,1)
(function,1)
(2,000,1)
(inner,1)
(assess,1)
(fluid.,1)
(blood,1)
((LE),1)
(this,4)
(accurate,,1)
(right,1)
(identifying,1)
(cell,9)
(results,4)
(mm,2)
(docetaxel-platinum,1)
(&#13;,7)
(field,1)
(motion.,1)
(patients,7)
(developed,1)
(some,1)
(represent,2)
(first,1)
(Currently,,1)
(exceeding,1)
(respiratory,2)
(without,1)
(just,2)
(state-augmented,1)
(99.2,,1)
(correlation,2)
(analysis,3)
(97.6,,1)
(restored.,1)
(cancer,8)
((6DoF):,1)
(S100A16-mediated,1)
(Conversely,,2)
(absorbed,1)
(Therefore,,1)
(CTs,1)
(into,1)
(outcome,1)
(coculture,1)
(potential,2)
(resonance,1)
(subtype,1)
(recorded,1)
(aberrations,2)
(Brain,1)
(Qin,,1)
(reserved.,1)
(doses,1)
(self-validating,,1)
(antibodies,4)
(Alternatively,,1)
(signal.&#13;,1)
(computational,1)
(Further,1)
((SCLC),2)
(F.,,1)
(Shiga,1)
(algorithms,1)
(analyzed.,1)
(combinations,1)
(high,4)
(receptor,1)
(2��.,1)
(metastasis,1)
(positions,1)
(rotation,1)
(6,1)
((NSCLC),1)
(blocked,1)
(Fang,,1)
(increased,2)
(frequency,,1)
(molecular,3)
(anticancer,1)
(brain.,1)
(despite,1)
(vaccines,1)
(largest,1)
(Miao,,1)
(disease,1)
(from,8)
(other,2)
(sequencing,,1)
(detected,1)
(cross-complementation,1)
(Motion,1)
(Using,2)
(Y.-H.,,1)
(believed,1)
(between,1)
(iodide,1)
(limbic,1)
(conditions,,1)
(information,1)
(report,1)
(precision,2)
(very,1)
(decreased,1)
(metastases.,1)
(electroencephalogram,1)
(aforementioned,1)
(mutations,3)
(prognosis,1)
(case,1)
(metastases,1)
(models,1)
(encountered,1)
(under,2)
(topologically,1)
(excision,1)
(neuroendocrine,1)
(overexpressing,1)
(B,1)
(have,1)
(lung,10)
(screening,1)
(modulating,1)
(components,1)
(we,5)
(This,5)
(obtained,1)
(enhanced,2)
(testing,1)
(function,,1)
(-0.3��2.0��,1)
(bellows,1)
(onto,2)
(With,1)
(predicted,1)
(largely,1)
(Our,8)
(targets,1)
(complement,1)
(tool,1)
(patients,,1)
(contents,,1)
(HBMECs,1)
(administration,1)
(promising,1)
(DBNL,1)
(article,1)
(presents,1)
(important.,1)
(deviation),1)
(&lt;1��,1)
(findings,1)
(profiling,1)
(stress.,1)
(weakened,1)
((DIR),1)
(IMRT,3)
(magnetic,1)
(medicine,1)
(effects.,1)
(as,6)
(survival,3)
(secondary,1)
(elevated,3)
(induce,1)
(apoptosis,1)
(better,1)
(automated,,1)
(optimizing,1)
(combination-drug,1)
(increased.,1)
(aimed,1)
(showed,5)
(ultracentrifugation,1)
(vaccines.,1)
(imaging,6)
(receiving,1)
(coverage.,1)
(is,16)
(Chen,,1)
(tumor-specific,2)
(images,3)
(built,1)
(cellular,1)
((����m),1)
(directions,,1)
(metastases,,1)
(map,1)
(phosphoproteomics,1)
(using,6)
(integrates,1)
(they,1)
(tumour,3)
(jaw,1)
(cancer,,3)
(heart,1)
((melanoma,,1)
(mechanisms,1)
(volume,3)
(discovery,1)
(Although,1)
(Left-Right,,1)
(T-shaped,1)
(after,2)
(partially,1)
(purified,1)
(effects,2)
(35,1)
(prohibitin,1)
(Basic,1)
(EGFR-inhibitory,1)
(couch,1)
(indicates,1)
(capable,2)
(mutational,2)
(biopsy,1)
(exosome,1)
(diagnosed,1)
(Cancer,1)
(error,1)
(0.1��0:9��,1)
(technique,6)
(beacon,1)
(results.,1)
(mediating,1)
(Three,1)
(mass,1)
(observed,1)
(coverage,1)
(Anterior-Posterior,1)
(geometry,,1)
(therefore,1)
(shapes/deformations,1)
(locally,1)
(Real-time,1)
(motion,8)
(only,2)
(complex,1)
(basic,1)
(vector),1)
(93,1)
(margin,4)
(experiments,1)
(optimal,1)
(signal,2)
(man,1)
(SABR,1)
(scans,1)
(optimise,1)
(peptides,1)
(Lung,1)
(test,1)
(J.-Q.,,1)
(2D,1)
(Z.-W.,,1)
(translational,1)
(advanced,4)
(can,3)
(retrospectively,1)
(discovered,1)
(potent,1)
(active,1)
(prognostic,1)
((mean),1)
(efficiently,1)
(immunotherapy,2)
(delivery,4)
(implemented,1)
(disease.,1)
(poor,,1)
(0.1��0:9,1)
(Zheng,,1)
(systems,2)
(self-validation,1)
(drug,1)
(intrafraction,3)
(driver,1)
(analyses,1)
((short,1)
(protected,1)
(freedom,1)
(pathway,1)
(brain,7)
(CT-guided,1)
(��-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic,1)
(with,27)
(targeted,1)
(92.1,,1)
(2,1)
(data,4)
(PTV,6)
(significantly,2)
(confers,1)
(followed,1)
(expression,1)
(identify,2)
(promote,1)
(metastasis.-Xu,,1)
(close,1)
(relies,2)
(understanding,1)
(Here,,1)
(exosome-mediated,1)
(proportion,1)
(role,1)
(CBCT,3)
(radiotherapy,3)
(their,1)
(unknown.,1)
(performed,2)
(rare,1)
(anterograde,1)
(demonstrated,3)
((SCLC).,1)
(images.,1)
(treatment.,1)
(IC,,1)
(important,3)
(requirements,1)
(accurate,1)
(removal,,1)
(poor.,1)
(approach,4)
(simulated,2)
(antigen,1)
(propose,1)
(radiotherapy.,1)
(approaches.,1)
